Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
ORENCIA (abatacept) Demonstrates Consistent Safety and Effectiveness Over 7 Years
Bristol Myers-Squibb Company, 06/18/09
The first, a long-term extension study, analysed ORENCIA's safety and efficacy profile over 7 years of treatment in rheumatoid arthritis patients who have had an inadequate response to methotrexate.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09
Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09
Article Search
Sponsor


See Latest Articles


